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nf2 knockout in Schwann cells and axons. We identified a 
severe re-myelination defect and sustained macrophage 
presence in the tumor tissue as major abnormalities. Strik-
ingly, treatment of tumor-developing mice after nerve crush 
injury with medium-dose aspirin significantly decreased 
schwannoma progression in this disease model. Our results 
suggest a multifactorial concept for schwannoma forma-
tion—emphasizing axonal factors and mechanical nerve 
irritation as predilection site for schwannoma development. 
Furthermore, we provide evidence supporting the poten-
tial efficacy of anti-inflammatory drugs in the treatment of 
schwannomas.
Keywords Schwannoma · Neurofibromatosis type 2 · 
NF2 · Tumor induction · Microenvironment · Sciatic 
nerve · Crush injury, tissue inflammation
Introduction
Schwannomas are benign Schwann cell-derived nerve 
sheath tumors that can occur either sporadically—in asso-
ciation with genetic syndromes such as schwannomatosis 
Abstract Schwannomas are predominantly benign nerve 
sheath neoplasms caused by Nf2 gene inactivation. Pres-
ently, treatment options are mainly limited to surgical 
tumor resection due to the lack of effective pharmacologi-
cal drugs. Although the mechanistic understanding of Nf2 
gene function has advanced, it has so far been primar-
ily restricted to Schwann cell-intrinsic events. Extracel-
lular cues determining Schwann cell behavior with regard 
to schwannoma development remain unknown. Here we 
show pro-tumourigenic microenvironmental effects on 
Schwann cells where an altered axonal microenvironment 
in cooperation with injury signals contribute to a persistent 
regenerative Schwann cell response promoting schwan-
noma development. Specifically in genetically engineered 
mice following crush injuries on sciatic nerves, we found 
macroscopic nerve swellings in mice with homozygous 
nf2 gene deletion in Schwann cells and in animals with 
heterozygous nf2 knockout in both Schwann cells and 
axons. However, patient-mimicking schwannomas could 
only be provoked in animals with combined heterozygous 
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or neurofibromatosis type 2 (NF2)—or as a result of thera-
peutic irradiation. The annual incidence of all schwanno-
mas has been estimated at 2.1 per 100,000 people [2]. Fur-
thermore, autopsy studies suggest a prevalence of 4.5 % for 
sporadic schwannomas in older individuals [44].
In virtually all sporadic schwannomas, as well as in NF2 
disease, schwannoma development is genetically caused 
by mutations in the Nf2 gene [55], which encodes for the 
merlin tumor suppressor protein. Although schwannomas 
are predominantly benign tumors, they can cause a signifi-
cant decline in life quality of afflicted individuals. Patients 
may present with pain, loss of sensation, paraesthesia and/
or weakness of extremities, depending on the position of 
the schwannoma and the nerve involved. NF2 disease can 
often mean lifelong deafness, as schwannomas predomi-
nantly appear at the vestibulocochlear nerves (vestibular 
schwannoma).
Current pharmacological treatment options for schwan-
nomas, e.g., bevacizumab treatment applying anti-VEGF 
monoclonal antibodies [40], are limited to disease stabili-
zation and can present severe side effects with long-term 
use [29]. Thus, therapeutic possibilities are often limited to 
surgical resection or radiosurgery of tumor tissue, with the 
additional risk of iatrogenic nerve damage. The multifo-
cality of tumors in patients with tumor predisposition syn-
dromes such as NF2, further challenges the practicability 
of surgical intervention. Hence, an urgent need exists for 
novel therapeutic approaches and a better understanding of 
the molecular and cellular mechanisms leading to schwan-
noma development.
The first animal model in the field bearing a Schwann 
cell-specific ablation of the tumor suppressor produced 
NF2-related tumor formation in mice [14]. However, only 
24 % of these genetically engineered animals (P0-Cre;Nf2fl/
fl) spontaneously developed schwannomas after 24 months. 
In another disease model, conditional nf2 gene deletion 
using the Periostin-Cre driver line (Postn-Cre;Nf2fl/fl) leads 
to the appearance of spinal, peripheral and cranial nerve 
schwannomas in all animals by the age of 10 months [13].
Loss of the merlin tumor suppressor protein, responsible 
for NF2 disease, has been intensively studied with respect 
to its ability to act on proliferation, migration, differentia-
tion and tumorigenesis. As a result, merlin has been dem-
onstrated to interact with a variety of different signaling 
pathways [8]. However, ongoing research mainly focuses 
on Schwann cell-intrinsic events. Recently, a neuronal 
function of merlin has been explored in more detail in our 
laboratory, emphasizing an implication in NF2-related neu-
ropathy [45] as well as in the bi-directional communication 
of axons and Schwann cells [47]. Specifically, we could 
show that merlin in neurons has a relevant impact on recep-
tor expression and intracellular signaling events of adjacent 
Schwann cells, by involving the Nrg1-ErbB pathway [36].
Tumor formation from Schwann cells into schwannomas 
is mainly thought to be dependent on bi-allelic inactivation 
of the Nf2 tumor suppressor gene, in line with Knudson’s 
two-hit hypothesis [22]. However, loss of heterozygosity 
(LOH) has reportedly been detected in only 67 % of NF2-
related and 56/57 % of sporadic schwannomas [15, 24]. 
Consistently, 40 % of all schwannomas were found to have 
at least one intact wild-type copy of the Nf2 gene remaining 
[51]. Intronic or promoter-region mutations within the Nf2 
gene, or mutations in genes other than Nf2, might lead to an 
overestimation of these numbers. Nonetheless, it appears 
unresolved whether inactivation of both the Nf2 alleles in 
Schwann cells is a prerequisite for schwannoma develop-
ment. Mechanistic and experimental studies resolving 
this issue are not currently available. In addition, it is not 
understood whether LOH occurs as early as in microscopic 
schwannoma precursors, referred to as tumorlets [49].
Where and why schwannomas ultimately appear also 
remains to be fully understood. Throughout life, most 
peripheral nerves are likely to be injured repetitively, due to 
compressive events and mechanical irritations. During the 
course of physiological nerve regeneration in the peripheral 
nervous system, Schwann cells lose contact with injured 
axons—thereby allowing them to de-differentiate and pro-
liferate again. However, in cases of pathological cell-to-cell 
communication, Schwann cells cannot properly align to 
axons and remain de-differentiated with continuous prolif-
eration [35, 39]. Axons are therefore thought to be essential 
for maintaining Schwann cells in a differentiated state dur-
ing adulthood.
Based on our previous findings indicating the impor-
tance of merlin in axon–Schwann cell signaling events 
[47], we hypothesized that genetically defined alterations 
of the nerve microenvironment could contribute to the ini-
tial events of schwannoma development [48]. Specifically, 
we aimed to investigate in mice whether the loss of just one 
merlin allele in both the axonal and Schwann cell compart-
ment of peripheral nerves, is sufficient to provoke long-
lasting regenerative abnormalities when challenged by an 
injury of the sciatic nerve. Another aim of this study was 
to improve the understanding of schwannoma biology with 
respect to minimal nerve trauma, which might predispose 
the lesion sites to enhanced Schwann cell proliferation.
Materials and methods
Experimental animals
All mice used in this study were handled in strict adherence 
to local governmental and institutional animal care regula-
tions. Animals had free access to food and water and were 
housed under constant temperature and humidity conditions 
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on a 12/12-h light/dark cycle. The following transgenic 
mouse strains were used for the study: Nf2flox animals 
(RIKEN BioResource Centre) were used to obtain con-
ditional Schwann cell-specific merlin knockout by cross-
ing with the P0-Cre line (The Jackson Laboratory, USA, 
stock 017928). In order to achieve neuron-specific loss of 
merlin, we mated Nf2flox animals with a mouse strain that 
expresses Cre recombinase under the neurofilament heavy 
class promoter (Nefh-Cre) (The Jackson Laboratory, stock 
009102). Furthermore, we generated animals showing dou-
ble Cre expression by breeding Nf2flox;P0-Cre mice with 
Nf2flox; Nefh-Cre animals (Nf2flox;P0-Cre;Nefh-Cre). 
Cre recombinase-specific genotyping was performed using 
the following primers: 5′-CCA CCA CCT CTC CAT TGC 
AC-3′ (forward) and 5′-ATG TTT AGC TGG CCC AAA 
TG-3′ (reverse) for P0-Cre [12], as well as 5′-GGG CCA 
CCG CGG ATA TAA AA-3′ (forward) and 5′-TGC GAA 
CCT CAT CAC TCG TT-3′ (reverse) for Nefh-Cre recom-
binase [17]. Mice bearing a complete heterozygous merlin 
knockout were generated by crossing Nf2flox animals with 
Amh-Cre mouse line (The Jackson Laboratory, USA, stock 
007915). This line expresses Cre recombinase driven by the 
Sertoli cell-specific promoter of the anti-Mullerian hormone 
(Amh) gene. Offsprings carry nf2 gene knockout in the ger-
mline (Nf2Δ/+) and spontaneously develop hepatocellular 
carcinoma, amongst other previously described tumor enti-
ties [30]. All animals and corresponding wild-type litter-
mates were on a mixed C57BL/6-FVB/N background. Both 
genders were used in equal numbers in this study.
Sciatic nerve crush injury
Unilateral injuries of sciatic nerves were accomplished 
according to a previously described method [4]. Briefly, 
8- to 10-week-old mice were anesthetized using 2 % iso-
flurane in 100 % oxygen. Fur was then removed from one 
hind limb. After an appropriate incision of the skin, the glu-
teal musculature was separated in order to reveal the right 
sciatic nerve. Using hemostatic forceps (Ultra Fine Hae-
mostat, #13021-12, tip width 0.6 mm, Fine Science Tools, 
Germany), the nerve was crushed once by the application 
of a defined pressure for 20 s. The locking mechanism of 
the hemostatic forceps with a series of interlocking teeth 
ensured reproducibility and standardization of crush injury. 
Finally, both the gluteal musculature and skin incision 
were sutured using non-absorbable surgical suture material 
(Polyethylene terephthalate; USP 4/0, #17218113, Catgut 
GmbH, Germany).
In vivo magnetic resonance imaging
Magnetic resonance imaging was performed with a dedi-
cated small animal MR scanner at 7.0 T (ClinScan 70/30, 
Bruker, Germany). The scanner is equipped with a high-
performance gradient system allowing maximal gra-
dient amplitude of 630 mT m−1 and a slew rate of up to 
6300 T m−1 s−1. The data were acquired using a birdcage 
polarized transmit/receive coil with an inner diameter of 
40 mm.
The MR sequence protocol consisted of a T1-weighted 
localizer sequence in three orthogonal planes, followed 
by a high-resolution fat-saturated T2-weighted 2D turbo 
spin-echo (TSE) sequence in coronal, sagittal and axial ori-
entation. Image parameters of the coronal and sagittal T2 
TSE sequence were as follows: time of repetition (TR)/
time of echo (TE)/flip angle (FA) = 4000 ms/47 ms/90°; 
field-of-view (FOV) = 90 × 36 mm2; matrix = 512 × 208; 
slice thickness (ST) = 0.8 mm, number of slices 
(NS) = 16; number of acquisitions (NA) = 4; spa-
tial resolution = 0.17 × 0.17 × 0.8 mm; acquisition 
time = 3 min 57 s. Image parameters of the fat-sat-
urated axial T2 TSE sequence were as follows: TR/
TE/FA = 2362 ms/90 ms/90°; FOV = 32 × 32 mm2; 
matrix = 256 × 256; ST = 0.6 mm, NS = 19; NA = 3; 
spatial resolution = 0.12 × 0.12 × 0.6 mm; acquisition 
time = 9 min 26 s.
Neuropathological assessment and evaluation
For the histological workup, paraformaldehyde-fixed nerve 
samples were embedded in paraffin, cut at the site of the 
largest diameter and mounted as a tissue microarray. Four-
micrometer thick cross sections were used for H&E stain-
ing and immunohistochemical labeling of S100 (1:8000, 
Dako, Germany), myelin protein zero (P0) (1:300, Bioss 
Antibodies, USA), phospho-c-Jun (Ser73, 1:500, Cell 
Signaling, USA, 8752), ErbB2 (1:500, Cell Signaling), p75 
(1:200, Millipore, USA, AB1554), Sox10 (1:200, Abcam, 
UK, ab155279), MMR/CD206 (1:200; R&D Systems; 
AF2535) and Arginase-1 (1:200, Santa Cruz, USA, H-52) 
in an automated Ventana stainer (Ventana Medical Systems, 
USA) using standard antigen retrieval protocols (CC1st, no 
pre-treatment for S100 protein). Onion bulbs and schwan-
noma-like structures were assessed in H&E-stained slides.
Human schwannoma samples
The investigation of human schwannomas was per-
formed using a tissue microarray comprising 30 sporadic 
schwannomas, 10 NF2-associated schwannomas and 
four schwannomatosis-associated schwannomas. The tis-
sue microarray was built from larger paraffin-embedded 
tumor specimens that were first reviewed by a neuro-
pathologist. Appropriate tumor areas were chosen and 
two tissue cylinders 1 mm in diameter were punched 
out and arranged in a new paraffin block. Labeling of 
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CD68 (1:100, Dako, #M0876, no pre-treatment), MMR/
CD206 (1:200; R&D Systems; AF2535) and Iba-1 (1:200, 
Wako, Japan) was carried out in an automated Ventana 
stainer. Bound antibodies were detected by the peroxidase 
method, using diaminobenzidine as chromogen (Ventana 
Medical Systems, #760-500). Labeling intensities were 
evaluated semi-quantitatively.
Immunohistochemistry and cell quantification
Immunohistochemistry was performed as described in 
[46]. Briefly, paraffin-embedded longitudinal sections of 
sciatic nerves were rehydrated, boiled in 10 mM sodium 
citrate buffer (pH 9) for 30 min in a microwave and subse-
quently treated with 0.5 % Triton X-100 for 10 min. Sec-
tions were then incubated in 0.2 % gelatin and 2 % goat 
serum diluted in PBS for at least 2 h, followed by submer-
sion in the primary antibody solution overnight at 4 °C. 
The following primary antibodies were used: P0 (1:200, 
Abcam, UK, ab39375), neurofilament (1:200, BioLegend, 
USA, SMI312), myelin basic protein (MBP) (1:500, Mil-
lipore, USA, MAB384), Ki-67 (1:200, eBioscience, USA, 
clone SolA15), Iba-1 (1:200, Wako, Japan) and p75 (1:200, 
Millipore, USA, AB1554). After vigorous washings, sec-
tions were incubated with the secondary antibody solu-
tion (Alexa488-, Alexa546- or Alexa647-conjugated anti-
mouse, -rat, -chicken and -rabbit antibodies (1:500 in PBS, 
Invitrogen, USA) at room temperature for 2 h. Finally, 
specimens were washed in PBS, counterstained using 
DAPI (1 µg/ml PBS, 10 min), dehydrated and embed-
ded. DAPI-stained cell nuclei or Iba-1-positive cells were 
counted using ImageJ plug-in ‘Particle Analysis’, from 
images acquired with 10× magnification after standardized 
background reduction and threshold setting.
Immunoblotting
Immunoblotting was performed as described in [32]. Sepa-
rate pooled protein lysates were prepared from both intact 
and crushed sciatic nerves. The following primary antibod-
ies were used: phospho-c-Jun (Ser73, 1:1000, Cell Signal-
ing, USA, 8752), Neuregulin 1 (1:250, Santa Cruz, USA, 
clone C-20), Erk (1:500, Cell Signaling, USA), phospho-
Erk (T202/Y204, 1:500, Cell Signaling, USA), ErbB2 
(1:500, Cell Signaling, USA), GAPDH (1:1000, Santa 
Cruz, USA, 6C5) and merlin (1:500, Santa Cruz, USA 
A19). Results were quantified using gel analysis software 
by ImageJ. Density values were normalized to GAPDH 
and appropriate controls of transfection or wild-type tis-
sue, respectively. In the case of phospho-specific detection 
of proteins, their acquired densities were referred to signals 
derived from related pan-antibodies that served as loading 
control (e.g., phospho-Erk to Erk signals).
Morphometric analysis of nerve sections
Analysis of axon caliber, myelination thickness and solid-
ity factor was conducted on semi-thin sections of sciatic 
nerves removed from transcardially perfused mice. Mice 
were perfused with a solution containing 3 % paraformal-
dehyde and 3 % glutaraldehyde in 0.1 M phosphate buffer 
(pH 7.4). Sections obtained from the distal part of the 
sciatic nerve were post-fixed for 1 h and kept in fixative 
including 3 % sucrose. Images of toluidine blue-stained 
semi-thin cross sections were taken using an Axioskop 2 
MOT (Carl Zeiss, Germany) equipped with a 100× immer-
sion oil objective and an Olympus XC50 digital camera 
(Olympus, Germany). Standardized settings for camera 
sensitivity, resolution (2576 × 1932 pixels) and bright-
ness of illumination were used for all micrographs. Image 
analysis was conducted with ImageJ version 1.48u. RGB 
color images obtained from semi-thin sections were split 
into single channels and the green channel was chosen for 
measurements. The image was contrasted using the auto-
function. Axon and myelin were circumscribed manually 
by the freehand selection tool. Based on the measured 
areas, the thicknesses of the axons and myelin sheaths were 
calculated. The solidity factor is a parameter for quantify-
ing the roundness of axons [45] and describes the area cov-
ered by a given structure in relation to the smallest convex 
area, which covers this structure; that is, the solidity fac-
tor of a round circle or ellipse would be 1, whereas a cir-
cle with an invagination would give a factor smaller than 
1. This solidity factor is superior to the circularity factor 
often used for measuring changes in surface structures, as it 
provides a factor to measure changes in surface curvatures 
independent of the plane of section. All calculations and 
statistics were done in R (http://www.r-project.org/).
Electron microscopic evaluation of nerves
For the preparation of ultra-thin sections of sciatic nerves, 
mice were perfused with a solution containing 2 % para-
formaldehyde and 2.5 % glutaraldehyde (vol/vol) in 0.1 M 
cacodylate buffer (pH 7.2). Tissue was post-fixed for 6 h 
and then kept in fixative that included 3 % sucrose (vol/
vol). Sections were cut from the mid part of the sciatic 
nerve close to the crushed area and stained with gadolinium 
acetate and lead citrate. Images were taken with a Zeiss 
Libra 120.
LOH analysis of nerve specimens
Simple repeats were identified by screening the sequence 
of the genomic nf2 region on mouse chromosome 11 
(4765845 to 4849536 in GRCM38) using a web tool [28]. 
Flanking primers were designed in intron 5 of the nf2 gene. 
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One primer was labeled with FAM at the 5′-end. The poly-
morphic marker was amplified from three pooled nerves of 
wild type and P0-Cre;Nefh-Cre;Nf2fl/+ mice, respectively, 
by means of polymerase chain reaction (PCR), for a total of 
30 cycles at an annealing temperature of 60 °C. The ampli-
fied marker was analyzed on a sequencer ABI310. As the 
amplification of polymorphic markers is PCR-based, the 
resolution of this standard method is naturally limited. Our 
unpublished data demonstrate that if an LOH is present in 
less than 25 % of cells in a sample, it will not be reliably 
detected (Kluwe 2016, manuscript submitted).
ASS treatment
Acetylsalicylic acid (ASS; aspirin) was purchased from 
Sigma-Aldrich (A5376; USA), firstly resolved in DMSO 
and further diluted in phosphate-buffered saline (PBS) to 
reach target concentration. For systemic administration, 
5 mg aspirin per kg body weight was intraperitoneally 
injected into mice every other day (5 mg aspirin per kg 
body weight in mice equates to approximately 375 mg dos-
age for humans). PBS solution without ASS served as vehi-
cle control.
In situ tumor size quantification
The right sciatic nerve of anesthetized animals was exposed 
surgically in order to assess sciatic nerve diameter as 
indicator for tumor size. Documentation was performed 
by video-assisted microscopy for each animal. Selected 
frames from the video files (using VirtualDub 1.6.19 soft-
ware) were used to determine maximal sciatic nerve diam-
eter using ImageJ.
Mouse cytokine detection in nerve lysates
For the unbiased detection of 40 different cytokines from 
nerve tissue, a commercially available kit was used accord-
ing to the manufacturer’s instructions (Mouse Cytokine 
Array Panel A, R&D Systems, USA). Pooled total nerve 
lysates (150 μg each), taken 8 months after crush injury 
from four animals per genotype, were used for this ELISA-
based method. The chemiluminescence of the membrane 
was analyzed by pixel density quantification using ImageJ. 
The relative changes of cytokine levels between samples 
were subsequently calculated.
Statistical analysis
Comparisons between groups were done using unpaired 
t test or one-way analysis of variance (one-way ANOVA) 
with subsequent Tukey’s multiple comparisons test 
(TMCT) for the comparison of multiple groups (SPSS 
software, Statistical Package for the Social Sciences, 
USA). For each experiment, we calculated the p value (P). 
Differences were considered significant when P < 0.05. All 
values are presented as means and the corresponding stand-
ard errors.
Results
Nerve crush injury induces macroscopic nerve swelling
Based on our previous findings on the importance of mer-
lin for axon-to-Schwann cell signaling events [47], we 
hypothesized that genetically defined alterations of the 
nerve microenvironment would also contribute to the ini-
tial events of schwannoma development. To that end, we 
generated conditional knockout mouse lines bearing cell 
type-specific deletion of merlin in neurons and/or Schwann 
cells (Supplementary Fig. 1). However, neither spontane-
ous schwannoma development nor obvious nerve swell-
ings were observed in any of the mouse lines within the 
first 10 months of lifespan (data not shown). Nevertheless, 
examination of semi-thin cross sections of sciatic nerves 
from 10-month-old mice (Supplementary Fig. 2) and 
subsequent morphometric analysis of nerve parameters, 
revealed a significant axon diameter decrease in nerves 
taken from P0-Cre;Nf2fl/fl and P0-Cre;Nefh-Cre;Nf2fl/+ 
mice (Supplementary Fig. 3); as well as reduced roundness 
of axons (solidity factor) in animals bearing a neuron- and/
or Schwann cell-specific loss of the nf2 gene (Supplemen-
tary Fig. 4). Furthermore, we could detect differences in 
myelin thickness and the g-ratio (Supplementary Fig. 5 
and 6). In sum—despite remarkable changes in nerve fine 
structure—spontaneous schwannoma growth could not be 
observed in the investigated mouse lines. In particular, the 
nerve structure of P0-Cre;Nefh-Cre;Nf2fl/+ mice was found 
to be significantly disrupted (Supplementary Fig. 2).
We therefore decided to challenge the pre-existing nerve 
alterations due to conditional merlin knockout (Supple-
mentary Fig. 1), by performing a unilateral crush injury to 
the right sciatic nerve of 2-month-old mice (Fig. 1a). We 
hypothesized that a combination of genetically defined 
conditions of the nerve microenvironment and regenerative 
processes could provoke schwannoma formation in vivo. 
In fact, cell proliferation following tissue injury normally 
subsides after the assaulting factor is removed, or the repair 
completed. But proliferating cells that have pre-existing 
mutations [43], or acquire DNA damage, continue to prolif-
erate in microenvironments rich in inflammatory cells [10].
Crush injuries were chosen in favor of cut injuries, 
because crushes better mimic a condition of mild nerve 
traumas that can occur during the lifetime of human indi-
viduals. All mice were examined regularly for behavioral 
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Fig. 1  Macroscopic analysis 
of nerve morphology 8 months 
after crush injury. a Schematic 
representation of the study 
protocol. b, c Representative 
images of one mouse 8 months 
after crush injury, indicating a 
relieving posture of the right 
hind limb (arrow) bearing the 
injured sciatic nerve when 
gently lifted at its tail. d–f 
T2-weighted coronal (d) and 
sagittal (e, f) MR images from a 
P0-Cre;Nefh-Cre;Nf2fl/+ mouse 
7 months after sciatic nerve 
crush. d Asterisks show the 
position of the left (uninjured) 
and right (crushed) sciatic 
nerve. Arrowhead indicates 
the spinal cord and hash marks 
the urine-filled bladder. Arrow 
in e, f depicts the anatomical 
course of the sciatic nerve close 
to the femur. The injured right 
sciatic nerve shows enlargement 
compared to the non-injured 
sciatic nerve on the left side. g–l 
Dissected sciatic nerves from 
10-month-old mice of indicated 
genotypes are shown. Crushed 
nerves (8 months post-injury) 
are shown at the top; intact 
nerves are depicted at the 
bottom of each representative 
image. Proximal nerve parts are 
on the right side of the images; 
distal parts on the left side. 
Scale bars represent 3 mm. m 
Quantification of macroscopic 
nerve swellings following nerve 
crush injury. A nerve swelling 
was counted when the nerve 
radius was at least doubled
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abnormalities during the months that followed the sciatic 
nerve injury. In this respect, none of the animals displayed 
obvious walking difficulties or a compromised general 
state of health. However, upon closer inspection—when 
gently lifted at their tail—animals with the homozy-
gous merlin deletion in Schwann cells (P0-Cre; Nf2fl/
fl) and the combined heterozygous knockout in Schwann 
cells and neurons (P0-Cre;Nefh-Cre;Nf2fl/+), presented 
with a relieving posture of the right hind limb bearing the 
injured sciatic nerve (Fig. 1b, c). Seven months after crush 
injury, a subset of mice was analyzed for nerve swellings 
using in vivo magnetic resonance imaging (MRI). In axial 
T2-weighted images, both P0-Cre;Nf2fl/fl and P0-Cre;Nefh-
Cre;Nf2fl/+ animals showed remarkable volume gain of 
the injured right sciatic nerve when compared to the unaf-
fected left sciatic nerve (Fig. 1d). Sagittal T2-weighted 
images depicting the nerve anatomy in more detail, further 
revealed long-segment unilateral swelling of the right sci-
atic nerve (Fig. 1e, f). Eight months after the crush injury, 
sciatic nerve tissue from all animals were dissected and 
collected. In order to assess macroscopic swelling, previ-
ously injured sciatic nerves were compared to unaffected 
nerves of the contralateral side (Fig. 1g–l). In summary, 
over 90 % of animals with the homozygous merlin dele-
tion in Schwann cells (P0-Cre;Nf2fl/fl) and the combined 
heterozygous knockout in Schwann cells and neurons 
(P0-Cre;Nefh-Cre;Nf2fl/+) presented with marked nerve 
swelling 8 months after nerve crush injury (Fig. 1m). In 
contrast, the other genotypes showed no comparable gain 
in nerve thickness.
Neuropathological assessment of crush‑induced sciatic 
nerve tumors
Focusing on the two genotypes that did develop macro-
scopic nerve swelling (P0-Cre;Nf2fl/fl and P0-Cre;Nefh-
Cre;Nf2fl/+), nerve cross sections were analyzed neu-
ropathologically 8 months after crush injury. Wild-type 
animals showed normal nerve composition after regenera-
tion (Fig. 2a, d), as well as regular expression of Schwann 
cell marker S100 (Fig. 2g) and P0 as indicator for Schwann 
cell differentiation in the myelin sheath (Fig. 2j). Both the 
neural crest lineage marker Sox10 (Fig. 2m) and the p75 
neurotrophin receptor (marker for immature non-myelinat-
ing Schwann cells) showed an expected staining pattern 
(Fig. 2m) [19, 21].
In contrast, injured nerves of P0-Cre;Nf2fl/fl animals 
bearing the homozygous merlin deletion in Schwann cells 
demonstrated imperfect regeneration, with large concentric 
multilayered onion bulbs indicative of for repetitive de- 
and re-myelination processes (Fig. 2b), as well as sporadic 
small disordered Schwann cell clusters (Fig. 2e). S100 
protein expression (Fig. 2h) and P0 expression (Fig. 2k) 
appeared to be decreased, in comparison to wild-type mice. 
While Sox10 immunoreactivity was normal (Fig. 2n), p75 
stainings suggest the presence of more immature non-mye-
linating Schwann cells (Fig. 2q).
In P0-Cre;Nefh-Cre;Nf2fl/+ animals, regeneration of sci-
atic nerves 8 months after crush injury was found to be even 
more disturbed, but onion bulbs appeared smaller and less 
structured (Fig. 2c) than in P0-Cre;Nf2fl/fl mice. Instead, 
larger clusters of unordered Schwann cells were detected, 
resembling tumorlets (microscopic neoplastic Schwann cell 
proliferations) observed in nerves of NF2 patients (Fig. 2f 
and Supplementary Fig. 7). Like tumorlets in sural nerve 
biopsies of NF2 patients [16], the disordered cell clusters 
presented an Antoni A growth pattern, the primary growth 
pattern of schwannoma in mice [50]. Focally increased 
S100 protein expression was observed within Schwann 
cell clusters (Fig. 2i), whereas P0 as a marker of differen-
tiation was not detectable in several regions of the tissue 
(Fig. 2l). Sox10 expression, however, indicates the pres-
ence of neural crest-derived cells (Fig. 2o), in combination 
with increased cell immaturity, as suggested by increased 
p75 immunoreactivity (Fig. 2r).
In summary, both genotypes that developed sciatic nerve 
swelling 8 months after crush injury showed neuropatho-
logical abnormalities, with the pattern more disordered in 
animals with the combined heterozygous nf2 gene deletion 
in Schwann cells and the neuronal compartment of periph-
eral nerves (P0-Cre;Nefh-Cre;Nf2fl/+). It was only in these 
haploinsufficient animals with reduced nf2 gene dosage, 
that Schwann cell clusters resembling NF2 patient tumor-
lets were observed. Furthermore, as in human schwanno-
mas, S100 protein expression was up-regulated while P0 
expression was lost [18].
Further ultrastructural analysis of sciatic nerve tis-
sue from 10-month-old P0-Cre;Nefh-Cre;Nf2fl/+ mice 
confirmed multiple signs of degeneration in intact (non-
crushed) nerves (Fig. 3a, b; Supplementary Fig. 2). But 
even more prominently, tumorlet-containing nerves 
appear structurally disordered exhibit concentric layers of 
Schwann cell processes and collagen around axons (onion 
bulbs) 8 months after crush injury (Fig. 3c–f).
Nerve regeneration defect in mice with nerve swellings 
after crush injury
In order to further explore detailed nerve anatomy 
8 months after crush injury, we performed immunohis-
tochemistry on longitudinal nerve sections covering the 
lesion site as well as the adjacent proximal and distal 
parts. We used fluorescent labeling of P0 as a marker for 
Schwann cell differentiation and myelin basic protein 
(MBP) as indicator for myelination as well as of neuro-
filaments for axonal tracing. By this means we found that 
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both axon integrity and myelination continuity were pre-
served in nerves from P0-Cre;Nf2fl/+ (Fig. 4c, d), Nefh-
Cre;Nf2fl/+ (Fig. 4e, f) and Nefh-Cre;Nf2fl/fl (Fig. 4g, h) 
animals, as well as in their wild-type littermates (Fig. 4a, 
b). Immunostaining for Ki-67—a well-established indica-
tor of cell proliferation—shows a patchy distribution in 
these nerves (Fig. 4b, d, f, g) without an obvious focus 
with regard to the crush site.
Fig. 2   Appearance of schwannoma-like structures and tumor-
lets in nerves from P0-Cre;Nefh-Cre;Nf2fl/+ mice. a–l Sciatic nerve 
cross sections of indicated genotypes 8 months after crush injury 
were either HE stained (a–f), or immunolabeled (brown color), for 
Schwann cell markers S100 (g–i) and P0 (j–l), as well as neural-crest 
marker Sox10 (m–o) and p75 as indicator for immature non-myeli-
nating Schwann cells (p–r). Cell nuclei are visualized in blue. Scale 
bar represents 20 μm
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In P0-Cre;Nf2fl/fl animals, the macroscopically swol-
len nerves showed distinct areas of pathological regen-
eration, as indicated by missing Schwann cell differen-
tiation (Fig. 4i). Overall Schwann cell differentiation 
and axon continuity, however, were preserved in crushed 
P0-Cre;Nf2fl/fl nerves (Fig. 4i, j). Ki-67 expression 
appeared locally restricted to the proximal, but not distal, 
part of the crushed nerve in relation to the wound site.
Strikingly, crushed nerves taken from P0-Cre;Nefh-
Cre;Nf2fl/+ animals displayed a severe re-myelination 
defect, beginning at the position of the experimental crush, 
with an overall disorganized pattern of remaining MBP-
positive, myelinated axons and the appearance of axons 
devoid of myelination (Fig. 4k). As regular myelination 
stopped at the crush site, a prominent increase in pro-
liferating cells (Ki-67 staining) was present at the border 
between preserved myelination and insufficient re-myeli-
nation (Fig. 4l). Furthermore, p75-positive cells indicating 
immature non-myelinating Schwann cells [43] were 
most abundantly expressed in sciatic nerve sections from 
P0-Cre;Nefh-Cre;Nf2fl/+ mice (Supplementary Fig. 8).
Signaling and protein expression changes in sciatic 
nerve lysates
We next aimed to decipher characteristic signaling path-
ways relevant to Schwann cell biology in our mouse 
model for schwannoma development. Using protein 
lysates from crushed and contralateral intact nerves of 
conditional knockout animals, we found that the expres-
sion of ErbB2, one of the most abundantly expressed 
receptor tyrosine kinases in human schwannomas [5], was 
up-regulated in P0-Cre;Nf2fl/fl mice and even more promi-
nently so in P0-Cre;Nefh-Cre;Nf2fl/+ animals (Fig. 5a 
and Supplementary Fig. 9). In line with previous obser-
vations from our group on intact mouse nerves [47], the 
Fig. 3  Electron microscopy reveals multiple signs of degeneration in 
crushed and uncrushed nerves of P0-Cre;Nefh-Cre;Nf2fl/+ mice. Rep-
resentative electron microscopic images of intact (a, b) and crushed 
(c–f) sciatic nerves (8 months post-injury) taken from P0-Cre;Nefh-
Cre;Nf2fl/+ mice. While myelinated axons and Remak bundles of 
various size (arrows in a, b) are frequent in intact nerves, myelinated 
axons and Remak bundles appear rarely in crushed nerves (c, d). 
Non-myelinated axons were mostly seen as single axons (arrows in 
d, f). Signs of degeneration such as collagen pockets (arrowhead in 
d, e), abnormally thin myelin sheath and layers of Schwann cell pro-
cesses enwrapping axons (c), bands of Bungner and axons with irreg-
ular myelin sheaths (hash in b) were mostly present in crushed, but, 
to a minor extent, also in intact nerves. In addition, accumulations of 
Schwann cells could be observed (asterisks in c). Scale bars in a, b, 
d represent 1 μm. Scale bar in c 5 μm. Scale bars in e, f represent 
0.2 μm
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post-cleavage product [56] of the axonal surface molecule 
Neuregulin1 type III (Nrg1 type III) showed reduced 
expression in nerves with a reduced amount of merlin 
protein in the neuronal nerve compartment (Fig. 5a and 
Supplementary Fig. 9). In essence, we observed a persis-
tent de-regulation of the Neuregulin1-ErbB pathway in 
both mouse lines that developed macroscopic nerve swell-
ings after nerve injury.
Fig. 4  Severe re-myelination defect in P0-Cre;Nefh-Cre;Nf2fl/+ mice 
following nerve crush. a–l Immunohistochemical stainings of lon-
gitudinal sciatic nerve sections prepared from indicated genotypes 
8 months after crush injury. Immunolabeling of P0, neurofilaments, 
MBP and Ki-67 indicates Schwann cell differentiation, axonal fibres, 
myelination and cell proliferation, respectively. Arrow in each image 
shows the position of the nerve crush. Orientation of nerves is stated 
as ‘distal’ and ‘proximal’. Asterisk in i emphasizes an area of defec-
tive re-myelination. Arrowheads in k indicate axons devoid of any 
myelin sheath. Asterisk in l marks concentration of Ki-67-positive 
cells at the edge of intact myelination. Scale bars represent 200 μm
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Downstream of receptor tyrosine kinase signaling fine-
tuning of the Ras-MAPK pathway is pivotal to resident 
Schwann cells in preventing tumorigenic transformation [33]. 
We therefore assessed the phosphorylation-dependent activa-
tion of the signaling component Erk1/2, as proxy for the Ras-
MAPK pathway in nerve lysates of 10-month-old mice. By 
relating phospho-specific immunoblot signals to total protein 
amounts, phosphorylation of Erk1/2 in sciatic nerve lysates 
was found to be enhanced upon crush in P0-Cre;Nf2fl/fl ani-
mals and even more markedly in P0-Cre;Nefh-Cre;Nf2fl/+ 
mice, compared to intact control nerves of each genotype 
(Fig. 5b and Supplementary Fig. 10).
Phospho-c-Jun expression, indicating Schwann cell 
immaturity [38], was also slightly increased in crushed 
Fig. 5  Signaling and protein 
expression changes in sciatic 
nerve lysates. a, b Immunoblot 
of sciatic nerve lysates (pooled 
tissue from at least three dif-
ferent animals per indicated 
genotype was prepared from 
crushed and intact sciatic nerves 
8 months after crush injury). a 
Immunoblot for receptor tyros-
ine kinase ErbB2, Neuregulin 
1 type III (Nrg1 type III), 
phospho-c-Jun and GAPDH 
as loading control (n = 3). For 
full-length blot see Supple-
mentary Fig. 9. b Immunoblot 
for phospho-Erk1/2 (pErk1/2). 
Total protein amount of Erk1/2 
served as loading control. 
Densitometric quantification 
of pErk1/2: Erk1/2 ratio was 
normalized to intact nerve tis-
sue for each genotype (n = 3). 
The observed increase in total 
Erk after crush injury in some 
genotypes (see also Sup-
plementary Fig. 10) remains 
unexplained but does not effect 
the ratio between phospho-Erk 
and overall Erk. For full-length 
blot see Supplementary Fig. 10. 
c–k Sciatic nerve cross sections 
of indicated genotypes 8 months 
after crush injury were immu-
nolabeled (brown color) for 
phospho-c-Jun, as a marker of 
cellular de-differentiation (c–e), 
ErbB2 (f–h) and Neuregulin 1 
(i–k). Cell nuclei are visualized 
in blue. Scale bars represent 
20 μm. l–q Human tissue 
sections taken from healthy 
sural nerve biopsies, as well as 
sporadic and NF2-associated 
schwannomas, were immu-
nolabeled (brown color) for 
Neuregulin 1 (l–n) and ErbB2 
(o–q). Cell nuclei are visualized 
in blue. Scale bars represent 
20 μm
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nerves from mice with the homozygous nf2 knockout 
in Schwann cells (P0-Cre;Nf2fl/fl) and in P0-Cre;Nefh-
Cre;Nf2 fl/+ mice (Fig. 5a and Supplementary Fig. 9). 
Consistently, phospho-c-Jun immunolabeling on sciatic 
nerve cross sections could be detected as a rare event in 
P0-Cre;Nf2fl/fl (Fig. 5d) and P0-Cre;Nefh-Cre;Nf2fl/+ mice 
(Fig. 4e), when compared to wild-type animals (Fig. 5c). 
Furthermore, the receptor tyrosine kinase ErbB2 showed 
highest expression after crush injury in P0-Cre;Nefh-
Cre;Nf2fl/+ mice (Fig. 5f–h). Nrg1 immunolabeling on sci-
atic nerve cross sections also appeared similar to the immu-
noblot results, although the applied Neuregulin 1 antibody 
cannot distinguish the different types of Nrg1 protein in 
immunohistochemistry (Fig. 5i–k). In human schwanno-
mas, ErbB2 (Fig. 5l–n) and Nrg1 (Fig. 5o–q) expression 
was found to be similarly changed compared to sural nerve 
biopsies from healthy human individuals.
In summary, we could detect clear signaling and protein 
expression changes as a consequence of both merlin knock-
out and crush injury. The most dramatic changes in terms 
of ErbB2 receptor upregulation and Ras-MAPK pathway 
activation were found in nerve tissue of P0-Cre;Nefh-
Cre;Nf2 fl/+ mice, correlating with the appearance of mac-
roscopic nerve swelling and schwannoma-like structures 
following nerve injury.
Tumor development in P0‑Cre;Nefh‑Cre;Nf2 fl/+ mice 
occurs without detectable LOH
Because neuropathologically validated schwannoma-like 
growth only occurred in crushed nerves of mice bearing 
deletion of one nf2 allele in both glial and neuronal com-
partments of peripheral nerves (P0-Cre;Nefh-Cre;Nf2fl/+), 
we hypothesized that LOH of the nf2 gene is dispensable 
for tumor initiation. Furthermore, we also aimed to deter-
mine whether LOH might occur during later stages of tumor 
progression. Using a polymorphic marker in intron 5 of the 
genomic nf2 sequence, we could detect two alleles—illus-
trated by two peak groups in nerve tissue from 2-month-old 
wild-type animals without crush injury (Fig. 6a). Strikingly, 
a similar pattern was also seen for the marker amplified 
from genomic DNA of nerve tissue taken from 2-month-old 
P0-Cre;Nefh-Cre;Nf2fl/+ animals without crush (Fig. 6b), as 
well as either 1 month (Fig. 6c) or 8 months (Fig. 6d) after 
crush injury. In stark contrast, hepatocellular carcinoma 
tissue derived from mice bearing a complete heterozy-
gous knockout of merlin, revealed a clear and total loss of 
the second nf2 allele using the same method (Fig. 6e). In 
line with our findings, at the protein level, merlin could be 
detected in nerve lysates of all tested genotypes 8 months 
after crush injury (Supplementary Fig. 11).
In summary, relevant LOH of the nf2 gene could not be 
detected in our schwannoma induction model. Considering 
the inherent resolution-limitation of microsatellite analysis 
as the standard technique for LOH detection, nf2 LOH can-
not be excluded in a minor subset of cells.
Macrophage presence in P0‑Cre;Nefh‑Cre;Nf2 fl/+ 
animals
In addition to dissecting the molecular signaling pathways 
leading to schwannoma development in our mouse models, 
we analyzed the sciatic nerve tissue for an unresolved inflam-
matory response at 8 months after crush injury. In fact, in 
many tumor entities, cells of the innate immunity, especially 
macrophages, have a strong impact on tumorigenic develop-
ment [1]. Furthermore, the essential role of macrophages dur-
ing peripheral nerve regeneration and Wallerian degeneration 
Fig. 6  LOH of nf2 gene is dispensable for schwannoma formation. 
a–e Microsatellite analysis of genomic DNA using a polymorphic 
marker in intron 5 of the murine nf2 gene. Pooled DNA from at least 
three sciatic nerves per indicated genotype was used to detect loss of 
heterozygosity. Tissue from hepatocellular carcinoma of Nf2Δ/+ mice 
was used as positive control for LOH. Grey highlighted peaks repre-
sent the two gene alleles
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is well known [34]. In sciatic nerves from P0-Cre;Nf2fl/+, 
Nefh-Cre;Nf2fl/+ and Nefh-Cre;Nf2fl/fl animals, as well as 
their wild-type littermates, Iba-1 immunoreactivity indicative 
of macrophages was not detectable beyond unspecific back-
ground staining (Fig. 7a–d). However, in nerves taken from 
P0-Cre;Nf2fl/fl animals (Fig. 7e) and even more prominently 
Fig. 7   Sustained inflammatory response after nerve crush in 
P0-Cre;Nefh-Cre;Nf2fl/+ mice. a–f Longitudinal sciatic nerve sec-
tions were prepared from indicated genotypes 8 months after crush 
injury and immunohistochemically stained for the macrophage 
marker Iba-1 (red). DAPI counterstaining indicates cell nuclei (blue). 
Arrow in each image shows the position of the nerve crush. Orienta-
tion of nerves is stated as ‘distal’ and ‘proximal’. Scale bars represent 
200 μm. g Quantification of cellular density in nerve tissue 8 months 
after crush injury, as measured by the number of DAPI-positive cell 
nuclei per area of tissue (one-way ANOVA analysis: ***P < 0.001; 
TMCT comparisons are depicted in the graph: *P < 0.05; **P < 0.01; 
n.s. not significant; n = 3 nerves per genotype; mean ± SD). h 
Quantification of Iba-1-positive cells in nerve tissue 8 months after 
crush injury (one-way ANOVA analysis: ***P < 0.001; TMCT com-
parisons are depicted in the graph: **P < 0.01; ***P < 0.001; n = 3 
nerves per genotype; mean ± SD)
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from P0-Cre;Nefh-Cre;Nf2fl/+ mice (Fig. 7f), macrophages 
were present in relevant numbers. Cell number quantifica-
tion revealed not only a total increase of cellular density in 
nerve sections of these two genotypes (Fig. 7g), but also a 
significantly enhanced and long-lasting presence of mac-
rophages 8 months after crush injury (Fig. 7h). Based on 
these quantifications, macrophages account for 19 ± 6 % 
(P0-Cre;Nf2fl/fl) and 36 ± 5 % (P0-Cre;Nefh-Cre;Nf2fl/+) 
of the total increase in cell number compared to wild-type 
nerve tissue. Strikingly, tumorlet-developing nerves from 
P0-Cre;Nefh-Cre;Nf2fl/+ animals contained the largest num-
ber of macrophages (Fig. 7h). Likewise, the occurrence of 
macrophages in schwannoma tissue could be confirmed in 
another established schwannoma mouse model (Supplemen-
tary Fig. 12), wherein all Postn-Cre;Nf2flox animals spon-
taneously develop schwannomas by 10 months of age [13].
The relevance and significance of chronic inflammation 
for the development and progression of schwannomas are 
not fully understood. However, intratumoral inflamma-
tion in schwannomas positively correlated with tumor size 
and growth in a retrospective study [11]. Macrophages are 
functionally plastic cells with distinct polarization states. 
While M1-type macrophages are thought to inhibit cell pro-
liferation, M2-type macrophages promote cell proliferation 
with high tissue-remodeling activity [31]. Hence, tumor-
associated macrophages primarily consist of M2-type mac-
rophage populations with little cytotoxicity towards tumor 
cells, because of their clearly defined cytokine armamentar-
ium [26]. Therefore, we tested for the presence of M2-type 
macrophages in sciatic nerve sections of P0-Cre;Nefh-
Cre;Nf2fl/+ mice, using an antibody raised against Argi-
nase-1 [27]. Indeed, Arginase-1 immunoreactivity was 
strongly present in nerve cross sections of P0-Cre;Nf2fl/
fl and P0-Cre;Nefh-Cre;Nf2fl/+ animals compared to wild-
type mice (Fig. 8a); suggesting the presence of M2-type 
macrophages in experimentally induced Schwann cell 
tumors. Importantly, M2-type macrophage immunolabeling 
of sciatic nerve samples showed a strong correlation with 
ErbB2 expression (P < 0.001). Ultimately, macrophage 
occurrence indicated by both CD68 and Iba-1 expression 
was also found in 28 out of 30 human biopsy samples from 
sporadic schwannomas, 9 out of 10 NF2-related schwan-
nomas and in 4 out of 4 investigated Schwann cell tumors 
associated with schwannomatosis (Fig. 8b). Using the mac-
rophage mannose receptor MMR/CD206 [53] as an addi-
tional non-lysosomal marker, M2-type macrophages were 
observed in human tissue of both sporadic and NF2-associ-
ated schwannomas (Fig. 8b).
Schwann cells have repeatedly been shown to pro-
duce chemotactic cues for macrophages, e.g., by mac-
rophage chemoattractant protein-1, leukemia inhibitory 
factor and different interleukins [54]. In order to iden-
tify soluble factors that might be causative for sustained 
macrophage presence, with the highest intensity in nerves 
of P0-Cre;Nefh-Cre;Nf2fl/+ animals, we performed an 
unbiased detection of 40 different cytokines in sciatic nerve 
lysates. Notably, we found various cytokines to be differen-
tially present in tissue from wild-type mice, P0-Cre;Nf2fl/
fl animals and schwannoma-developing P0-Cre;Nefh-
Cre;Nf2fl/+ mice (Fig. 8c and Supplementary Fig. 13). Sev-
eral cytokines with known association to chronic inflam-
mation (such as TNFα, IL-6 and IL-10) showed the highest 
levels in P0-Cre;Nefh-Cre;Nf2fl/+ mice [23]. Furthermore, 
IL-6 and SDF-1/CXCL12, which exhibited the strongest 
levels in P0-Cre;Nefh-Cre;Nf2fl/+ animals, are reportedly 
capable of inducing transactivation of ErbB2 receptor in a 
ligand-independent mechanism [7, 41].
In order to experimentally test a cause and effect rela-
tionship between chronic inflammation and schwannoma 
growth, we administered medium-dose aspirin (5 mg per 
kg equates to a dose of approximately 375 mg for humans) 
as commonly used anti-inflammatory drug to P0-Cre;Nefh-
Cre;Nf2fl/+ mice after tumor induction by nerve crush 
injury (Fig. 9a). Following systemic treatment through 
intraperitoneal injections for 3 months, tumor size was 
quantified in situ (Fig. 9b and Supplementary Fig. 14). 
Strikingly, aspirin-treated P0-Cre;Nefh-Cre;Nf2fl/+ animals 
had significantly smaller tumors than vehicle-treated mice 
of the same genotype, as indicated by a relevant reduc-
tion in the maximum sciatic nerve diameter. Subsequent 
immunohistochemical analysis of longitudinal nerve sec-
tions indicated a decrease in the absolute number of mac-
rophages (Fig. 9d), but not when related to the area of tis-
sue section (Fig. 9e).
Taken together, our data highlights an unresolved 
inflammation in two different mouse models of schwan-
noma development and human schwannoma tissue. For the 
first time, we provide causal evidence for the relevance of 
chronic inflammation in schwannoma development, as anti-
inflammatory treatment significantly reduces tumor pro-
gression in our in vivo disease model.
Discussion
Schwann cell-intrinsic signaling mechanisms leading to 
tumorigenic transformation and schwannoma development 
have been explored in great detail. However, the identifi-
cation of diversified signaling events related to the merlin 
tumor suppressor protein has yet to lead to the develop-
ment of better therapeutic options for the management of 
sporadic or NF2-related schwannomas. Therefore, beyond 
‘watchful waiting’, surgical resection of nerve sheath 
tumors is often the only available treatment. This study 
aimed to investigate the importance of the nerve micro-
environment and Schwann cell-extrinsic factors for the 
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Fig. 8   Appearance of M2-type macrophages in merlin-deficient 
nerves after crush injury and human schwannoma samples. a Rep-
resentative images of sciatic nerve cross sections from indicated 
genotypes. Immunolabeling of Arginase-1 as a marker for M2-type 
macrophages shows strong expression in P0-Cre;Nf2fl/fl and 
P0-Cre;Nefh-Cre;Nf2fl/+ mice, in comparison to wild-type (WT) lit-
termates. Scale bars represent 100 μm. b Representative images 
of human schwannoma samples from a tissue microarray. Immu-
nostainings against macrophage markers CD68 and Iba-1, as well 
as M2-type macrophage marker MMR/CD206, indicate macrophage 
occurence in sporadic, NF2-associated and Schwannomatosis-associ-
ated schwannomas. Scale bars represent 50 μm (upper panel), 10 μm 
(middle panel) and 20 μm (lower panel), respectively. c Cytokine 
levels in pooled lysates of at least four individual sciatic nerves per 
indicated genotype (n = 2). Densitometric quantification is shown as 
median value. For full-length blots see Supplementary Fig. 13
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development of schwannomas. In line with previous find-
ings suggesting a key role for axons in Schwann cell con-
trol [9], we provide experimental evidence that the axonal 
compartment of peripheral nerves contributes to schwan-
noma formation. In fact, 12 of the 13 animals with the hete-
rozygous knockout of the nf2 gene in neurons and Schwann 
cells (P0-Cre;Nefh-Cre;Nf2fl/+), developed macroscopic 
nerve swellings at the same position where a single crush 
injury had been performed 8 months earlier. Strikingly, 
the marked swelling was not just restricted to the crush 
site, but expanded several millimeters into the distal part 
of the nerve where branching of the sciatic nerve into 
tibial and common peroneal nerve occurs. Crush injury-
induced macroscopic nerve swelling was also observed 
in another mouse model frequently used to mimic NF2 
disease by conditional biallelic nf2 knockout in Schwann 
Fig. 9  Systemic aspirin admin-
istration decreases schwannoma 
progression in P0-Cre;Nefh-
Cre;Nf2fl/+ mice. a Schematic 
representation of the aspirin 
(ASS) treatment protocol. b 
Representative images showing 
the method for in situ tumor 
size quantification. The crushed 
sciatic nerve was exposed 
surgically in order to assess 
the maximum sciatic nerve 
diameter following as indicator 
for tumor size. c Quantifica-
tion of maximum sciatic nerve 
diameters in wild type (WT) 
and P0-Cre;Nefh-Cre;Nf2fl/+ 
mice, 3 months after crush 
injury. Mice received sys-
temic administration of either 
medium-dose aspirin (5 mg 
per kg ASS i.p.) or vehicle 
(**P < 0.01; n = 7 mice per 
genotype; mean ± SD). d Lon-
gitudinal sciatic nerve sections 
were prepared from vehicle or 
aspirin-treated P0-Cre;Nefh-
Cre;Nf2fl/+ mice 3 months after 
crush injury and immunohis-
tochemically stained for the 
macrophage marker Iba-1 (red). 
DAPI counterstaining indicates 
cell nuclei (blue). Scale bars 
represent 200 μm. e Quantifica-
tion of Iba-1-positive cells nerve 
tissue 3 months after crush 
injury, taken from aspirin and 
vehicle-treated P0-Cre;Nefh-
Cre;Nf2fl/+ mice (n.s. not 
significant; n = 3 nerves per 
genotype; mean ± SD)
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cells (P0-Cre;Nf2fl/fl). However, neuropathological assess-
ment of the macroscopic nerve swellings revealed that NF2 
patient-resembling tumors and Schwann cell de-differenti-
ation only occurred in animals with cooperative nf2 gene 
loss in axons and adjacent Schwann cells (P0-Cre;Nefh-
Cre;Nf2fl/+). Our findings suggest that axon-derived 
instructive cues for Schwann cells might be implicated in 
schwannoma formation. Because of the bidirectional com-
munication between cells and their surrounding context, 
the microenvironment has been proven to be critical for 
both tissue homeostasis and tumor growth [42]. Consistent 
with previous work from our group and others, we provide 
more evidence that the Neuregulin1-ErbB network, crucial 
for normal cell-to-cell communication between Schwann 
cells and axons, is persistently disturbed in merlin-deficient 
nerve tissue.
The reason for the preference of the vestibular nerve 
for schwannoma growth remains profoundly obscure [52]. 
However, our data raise the question of whether mechani-
cal irritation of nerves or local nerve injury, respectively, 
can act as predilection sites for schwannoma develop-
ment—comparable to neurofibroma, which are often 
viewed as unrepaired wounds [3, 43]. Remarkably, NF2-
related schwannomas often occur at localizations where 
peripheral nerves are in close proximity to bony struc-
tures, e.g., spinal nerves emerging from the spinal column 
through the intervertebral foramen and the vestibular nerve, 
which uses the internal auditory meatus as a passageway. 
However, while the connection between neuromas and de-
regulated nerve regeneration after injury (traumatic neu-
roma) is widely accepted [6], schwannoma formation after 
mechanical nerve irritation has not been studied in a sys-
tematic manner.
Wounding of the sciatic nerve has previously been 
shown to induce a transient inflammatory response involv-
ing macrophages [34]. On the other hand, sustained or 
chronic tissue inflammation is known to drive tumor forma-
tion [25]. In our model, we can clearly correlate the for-
mation of schwannomas with the presence of macrophages. 
Furthermore, we provide evidence that at least a subset of 
macrophages shows ‘alternatively activated’ M2 polari-
zation, which can exert anti-inflammatory but pro-tumo-
rigenic functions. Importantly, in each mouse line of this 
study, macrophages have a wild-type genetic setup and are 
spared from genetic modifications. The finding that virtu-
ally all sporadic and NF2-associated human schwannomas 
tested in this study show macrophage presence, further sup-
ports the concept that schwannoma formation is promoted 
by an unresolved inflammatory response. In line with our 
own causal evidence, a recent retrospective study found 
that aspirin intake as an anti-inflammatory drug correlated 
with slowed growth of vestibular schwannomas in patients 
[20].
The results presented here enable us to clearly correlate 
the appearance and number of non-differentiated, non-mye-
linating, Schwann cells at the lesion site with the occur-
rence of macrophages. This in turn coincides with substan-
tial cellular proliferation resulting in tumorlet formation, 
identical to NF2-related schwannomas again underlining 
the notion that tumors do not diversify solely in terms of 
genetic alterations, but also with respect to the nature of 
their microenvironment [42].
The necessity of bi-allelic Nf2 gene (e.g., due to LOH) 
for schwannoma development for human individuals is 
a long-standing clinical hypothesis. However, a growing 
number of tumor suppressor genes have been shown not 
to conform to the classical two-hit hypothesis proposed by 
Alfred Knudson [37]. In fact, the data on LOH frequency in 
schwannoma samples are not entirely conclusive through-
out the existing literature. Therefore, we aimed to investi-
gate whether LOH might not be a necessary prerequisite 
for schwannoma initiation. From the mouse model and the 
LOH detection technique applied in this study, we conclude 
that LOH of the nf2 gene is neither required for initiation 
nor progression of schwannomas, considering the inher-
ent detection limit of the chosen technique. Nonetheless, 
other genetic mutations might occur during the course of 
schwannoma growth that remain to be detected or con-
sidered. This potential necessity for other genetic events 
to occur to prompt schwannoma formation is further sup-
ported by our results from P0-Cre;Nf2fl/fl animals—where 
nerve injury is not sufficient to induce schwannomas, 
despite biallelic nf2 gene inactivation. We therefore suggest 
performing a systematic and unbiased analysis of genetic 
alterations found in human schwannoma samples, e.g., by 
whole-genome sequencing.
In essence, our data suggest that a Schwann cell-focused 
pathogenesis of schwannoma development is insufficient. 
Instead, we provide evidence for a multi-leveled impor-
tance of the nerve microenvironment, where instructive 
cues from axons and macrophage presence play important 
roles in combination with failed regenerative processes 
of afflicted nerves. Clearly, microenvironmental consid-
erations further complicate the already challenging task of 
understanding tumors. On the other hand, this increasingly 
complex construct of tumor development presents more 
opportunities for the identification of potential new thera-
peutic targets, urgently needed for debilitating tumor pre-
disposition syndromes like NF2 disease.
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